This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Gruppo Italiano per lo Studio della Streptochinasi nell’Infarto Miocardico (GISSI) (1986) Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction. Lancet 22:397–402
ISIS-2 (Second International Study of Infarct Survival) Collaborative Group (1988) Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2. Lancet 2:349–360
GISSI-2 (1990) A factorial randomised trial of alteplase versus streptokinase and heparin versus no heparin among 12490 patients with acute myocardial infarction. Lancet 336:65–71
The GUSTO Investigators (1993) An international randomised trial comparing four thrombolytic strategies for acute myocardial infarction. N Engl J Med 329:673–682
Every NR, Parsons LS, Hlatky M et al for the TIMI Study Group (1985) The Thrombolysis in Myocardial Infarction (TIMI) trial: phase I findings.N Engl J Med 312:932–936
Assessment of the Safety and Efficacy of a New Thrombolytic (ASSENT-2) Investigators (1999) Single-bolus tenecteplase compared with front-loaded alteplase in acute myocardial infarction: the ASSENT-2 double-blind randomised trial. Lancet 354:716–722
Topol EJ (1998) Toward a new frontier in myocardial reperfusion therapy. Circulation 97:211–218
Keeley EC, Boura JA, Grines CL (2003) Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials. Lancet 361:13–20
Auer J, Berent R, Weber T et al (2003) Primary angioplasty or thrombolysis for acute myocardial infarction? (Letter to the editor). Lancet 361:965–966
Melandri G (2003) Primary angioplasty or thrombolysis for acute myocardial infarction? (Letter to the editor). Lancet 361:966
Management of Patients With ST-Elevation Myocardial Infarction ACC/AHA Pocket Guideline Based on the ACC/AHA Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction, from American Heart Association website, July 2004
Gibson CM, Jennings LK, Murphy SA for the INTEGRITI Study Group (2004) Association between platelet receptor occupancy after eptifibatide (integrilin) therapy and patency, myocardial perfusion, and ST-segment resolution among patients with ST-segment-elevation myocardial infarction: an INTEGRITI (Integrilin and Tenecteplase in Acute Myocardial Infarction) substudy. Circulation 110:679–684
Savonitto S, Armstrong PW, Lincoff AM et al (2003) Risk of intracranial haemorrhage with combined fibrinolytic and glycoprotein IIb/IIIa inhibitor therapy in acute myocardial infarction. Dichotomous response as a function of age in the GUSTO V trial. Eur Heart J 20:1807–1814
Lincoff AM, Califf RM, Van de Werf F et al for the Global Use of Strategies To Open Coronary Arteries Investigators (GUSTO) (2002) Mortality at 1 year with combination platelet glycoprotein IIb/IIIa inhibition and reduced-dose fibrinolytic therapy vs conventional fibrinolytic therapy for acute myocardial infarction: GUSTO V randomized trial. JAMA 288:2130–2135
Gibson CM, Cannon CP, Murphy SA et al for the TIMI Study Group (2002) Relationship of the TIMI myocardial perfusion grades, flow grades, frame count, and percutaneous coronary intervention to long-term outcomes after thrombolytic administration in acute myocardial infarction. Circulation 105:1909–1913
Gibson CM, Cannon CP, Murphy SA et al for the TIMI (Thrombolysis In Myocardial Infarction) Study Group (2000) Relationship of TIMI myocardial perfusion grade to mortality after administration of thrombolytic drugs. Circulation 101:125–130
Giugliano RP, Sabatine MS, Gibson CM et al (2004) Combined assessment of thrombolysis in myocardial infarction flow grade,myocardial perfusion grade, and ST-segment resolution to evaluate epicardial and myocardial reperfusion. Am J Cardiol 93:1362–1367, A5-A6
Beran G, Lang I, Schreiber W et al (2002) Intracoronary thrombectomy with the XSizer catheter system improves epicardial flow and accelerates ST-segment resolution in patients with acute coronary syndrome: a prospective, randomized, controlled study. Circulation 105:2355–2360
Wu CJ, Yang CH, Fang CY et al (2004) Six-month angiographic results of primary angioplasty with adjunctive PercuSurge GuardWire device support: evaluation of the restenotic rate of the target lesion and the fate of the distal balloon occlusion site. Catheter Cardiovasc Interv 64:35–42
Antman EM, Van de Werf F (2004) Pharmacoinvasive therapy: the future of treatment for ST-elevation myocardial infarction. Circulation 109:2480–2486
Morrison JL, Verbeek PR, McDonald AC et al (2000) Mortality and pre-hospital thrombolysis for acute myocardial infarction: a meta-analysis. JAMA 283:2686–2692
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2005 Springer-Verlag Italia
About this paper
Cite this paper
Chiarella, F., Nicolino, A., Paonessa, K., Rossi, F. (2005). New Strategies for Treating Myocardial Infarctions. In: Gulizia, M.M. (eds) Emerging Pathologies in Cardiology. Springer, Milano . https://doi.org/10.1007/88-470-0341-5_3
Download citation
DOI: https://doi.org/10.1007/88-470-0341-5_3
Publisher Name: Springer, Milano
Print ISBN: 978-88-470-0311-8
Online ISBN: 978-88-470-0341-5
eBook Packages: MedicineMedicine (R0)